| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-03-14 | Meridian Venture Partners II GP, L.P. | ANI PHARMACEUTICALS INC | 1,419,381 | 6.7% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | ANI PHARMACEUTICALS INC | 1,288,972 | 6.3% | EDGAR |
| SC 13G | 2024-02-12 | Rubric Capital Management LP | ANI PHARMACEUTICALS INC | 1,125,000 | 5.5% | EDGAR |
| SC 13G/A | 2024-01-23 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 2,524,660 | 12.4% | EDGAR |
| SC 13D/A | 2024-01-17 | Esjay LLC | ANI PHARMACEUTICALS INC | 932,620 | 4.6% | EDGAR |
| SC 13D/A | 2023-12-18 | Meridian Venture Partners II GP, L.P. | ANI PHARMACEUTICALS INC | 1,644,381 | 8.1% | EDGAR |
| SC 13D/A | 2023-12-05 | Esjay LLC | ANI PHARMACEUTICALS INC | 982,620 | 4.8% | EDGAR |
| SC 13D/A | 2023-08-18 | Meridian Venture Partners II GP, L.P. | ANI PHARMACEUTICALS INC | 1,819,259 | 9.0% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,983,237 | 11.4% | EDGAR |
| SC 13G/A | 2023-01-20 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,983,237 | 11.4% | EDGAR |
| SC 13D/A | 2022-12-12 | Meridian Venture Partners II GP, L.P. | ANI PHARMACEUTICALS INC | 2,019,259 | 11.6% | EDGAR |
| SC 13D | 2022-03-02 | Esjay LLC | ANI PHARMACEUTICALS INC | 1,332,620 | 8.0% | EDGAR |
| SC 13G/A | 2022-02-07 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,686,613 | 11.8% | EDGAR |
| SC 13G/A | 2021-01-27 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,589,228 | 12.9% | EDGAR |
| SC 13G/A | 2020-02-04 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,547,749 | 12.8% | EDGAR |
| SC 13G/A | 2019-01-24 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,368,668 | 11.6% | EDGAR |
| SC 13G | 2018-02-15 | Allianz Global Investors U.S. Holdings LLC | ANI PHARMACEUTICALS INC | 73,388 | 0.6% | EDGAR |
| SC 13G/A | 2018-01-19 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,274,351 | 10.9% | EDGAR |
| SC 13G/A | 2017-08-10 | BlackRock Inc. | ANI PHARMACEUTICALS INC | 1,175,529 | 10.1% | EDGAR |
| SC 13G | 2017-02-14 | Allianz Global Investors U.S. Holdings LLC | ANI PHARMACEUTICALS INC | 684,306 | 5.7% | EDGAR |